肺动脉高压中转化生长因子β I型受体的显像研究
该研究评估了两种靶向ALK5的PET示踪剂[11C]LR111和[18F]EW-7197在野百合碱(MCT)和Sugen/缺氧(SuHx)诱导的肺动脉高压(PAH)模型中显像ALK5的效果。体外实验显示[11C]LR111代谢稳定性最高且与ALK5结合可被SB431542阻断,而体内实验[18F]EW-7197表现最佳,注射后15分钟SuHx和MCT肺摄取分别较对照高2.5倍和1.4倍。因此[18F]EW-7197是有前景的PAH ALK5 PET示踪剂。
要点
- [11C]LR111代谢稳定性最高,60分钟后大鼠血浆中完整示踪剂仍存46±2%。
- 体外放射自显影中[11C]LR111在SuHx和MCT肺的结合分别较对照高3.2倍和1.5倍。
- 体内[18F]EW-7197注射后15分钟SuHx和MCT肺摄取分别较对照高2.5倍和1.4倍。
核心结论
- [18F]EW-7197是用于肺动脉高压中ALK5显像的有前景PET示踪剂。
研究设计与样本
- 研究评估了两种靶向ALK5的PET示踪剂[11C]LR111和[18F]EW-7197,在MCT和SuHx诱导的PAH模型中进行体外和体内研究。
主要发现
- [11C]LR111代谢稳定性最高,60分钟后大鼠血浆中完整示踪剂仍存46±2%。
- 体外放射自显影中[11C]LR111在SuHx和MCT肺的ALK5结合分别较对照高3.2倍和1.5倍,且可被SB431542阻断。
- 体内[18F]EW-7197注射后15分钟SuHx和MCT肺摄取分别较对照高2.5倍和1.4倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transforming growth factor β (TGFβ) activity is perturbed in remodelled pulmonary vasculature of patients with pulmonary arterial hypertension (PAH), cancer, vascular diseases and developmental disorders. Inhibition of TGFβ, which signals via activin receptor-like kinase 5 (ALK5), prevents progression and development of experimental PAH. The purpose of this study was to assess two ALK5 targeting positron emission tomography (PET) tracers ([11C]LR111 and [18F]EW-7197) for imaging ALK5 in monocrotaline (MCT)- and Sugen/hypoxia (SuHx)-induced PAH. Both tracers were subjected to extensive in vitro and in vivo studies. [11C]LR111 showed the highest metabolic stability, as 46 ± 2% of intact tracer was still present in rat blood plasma after 60 min. In autoradiography experiments, [11C]LR111 showed high ALK5 binding in vitro compared with controls, 3.2 and 1.5 times higher in SuHx and MCT, respectively. In addition, its binding could be blocked by SB431542, an adenosine triphosphate competitive ALK5 kinase inhibitor. However, [18F]EW-7197 showed the best in vivo results. 15 min after injection, uptake was 2.5 and 1.4 times higher in the SuHx and MCT lungs, compared with controls. Therefore, [18F]EW-7197 is a promising PET tracer for ALK5 imaging in PAH.
引用
- Rotteveel L, Poot AJ, Kooijman EJM, et al. Imaging the TGFβ type I receptor in pulmonary arterial hypertension. EJNMMI Res. 2023. PMID: 36947258. doi:10.1186/s13550-023-00966-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。